Leaders inAnimal Therapeutics
Developing regulatory approved first-in-class animal pharmaceuticals to provide a new standard of care in animal health
A LEADING RESEARCH NETWORKSome of the world brightest minds
We’re fast-tracking R&D by leveraging validated medical cannabis research on humans and adapting it to animal health.
MAKING A DIFFERENCEEvery companion animal deserves to be cared for
We’re focused on making a difference in the animal health industry with products that are safe and proven to work
The animal population is ageing and age related disease is growing at a quicker rate than new product innovation and development.
It’s estimated that over 60% of dogs between the ages of 7 and 11 years will experience arthritis, 1 in 2 will get some form of cancer and 1 in 4 dogs will die from the disease. 61% of felines over the age of 6 have Arthritis in at least 1 joint and 30% will be affected by a tumour at some point in their lives.
The medication available to pets for these indications can provide negative side effects including nausea, loss of appetite, depression and internal bleeding. Pets are also becoming increasingly resistant to non-steroidal anti-inflammatory drugs and other pharmaceutical therapies.
CannPal is working to further explore the natural healing abilities of cannabinoids, to develop novel and efficacious therapies for your companions, without the associated negative side effects, to enhance their quality of life.
Developing a number of pain management drugs, focusing on inflammation, arthritis and post-surgery pain.
Drastically improvedBehaviour issues
With a focus on behaviour modifying agents for use in problem dogs, including separation anxiety & aggression.
Reduced and remediedSkin disease
Innovative topical lotions and applications to treat Atopic Dermatitis and other skin disease, including itchiness.
Leading the packWhat makes us different
We’ve aligned ourselves with some of the worlds leading veterinary research organisations across the globe.
Our strategic partners include global market leading cannabis cultivators and oil suppliers.
We’re committed to providing veterinarians with safe and efficacious, regulatory approved medicines.
Our advisers are industry thought leaders with experience in commercial veterinary drug development and research
We have an innovative pipeline targeting specific unmet needs in the pet pharmaceutical market.
A diversified portfolio to expose CannPal to long term and short term revenues through OTC and regulatory therapies.
CannPal has become the first animal health company to receive a sponsor fee waiver for a cannabinoid...
The Animal Health sector is hot and the medical cannabis sector is even hotter. Merchant Opportuniti...
CBD (Cannabidiol) the phytocannabinoid derived for cannabis, is now officially classified as an ingr...